HPS Pharmacies wish to advise that Pfizer is experiencing a supply interruption for lidocaine ampoules as follows:

Lignocaine Injection
Lidocaine (lignocaine) HCl 1% (50mg/5mL)
ARTG 49296

Lignocaine Injection
Lidocaine (lignocaine) HCl 2% (100mg/5mL)
ARTG 49293

Normal supplies of Pfizer Lignocaine Injection 1% are expected to return in early September 2023, with supplies of Pfizer Lignocaine Injection 2% expected to return by early October 2023.

Limited supplies of alternative products are available, including Lidocaine-Baxter 1% 5mL, Lidocaine Noridem 1% 5mL, and Lidocaine Juno 2% 5mL. The approved indications may vary between brands. Please consult the product information for further details.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Pfizer on (08) 93620666, or your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates